Here’s what you should know:
1. The company is relocating its researchers to develop new talent in pursuit of additional revenue sources.
2. Takeda will select the researchers from a candidate pool of its current researchers.
3. Takeda has not announced how long the researchers will be in the U.S.
More articles on gastroenterology:
Berkshire Health Systems adds gastroenterologist Dr. Jacques Reichling — 3 key notes
GI leader to know: Dr. Mark Eisner of Florida Medical Clinic
OrphoMed secures $39M for IBS-D drug development — 3 insights
